DexCom (Germany) Performance

DC4 Stock  EUR 61.91  0.26  0.42%   
On a scale of 0 to 100, DexCom holds a performance score of 10. The firm shows a Beta (market volatility) of 0.6, which means possible diversification benefits within a given portfolio. As returns on the market increase, DexCom's returns are expected to increase less than the market. However, during the bear market, the loss of holding DexCom is expected to be smaller as well. Please check DexCom's value at risk, downside variance, and the relationship between the maximum drawdown and potential upside , to make a quick decision on whether DexCom's price patterns will revert.

Risk-Adjusted Performance

Fair

 
Weak
 
Strong
Compared to the overall equity markets, risk-adjusted returns on investments in DexCom Inc are ranked lower than 10 (%) of all global equities and portfolios over the last 90 days. Despite nearly fragile basic indicators, DexCom reported solid returns over the last few months and may actually be approaching a breakup point. ...more
Last Split Factor
4:1
Last Split Date
2022-06-13
1
Morgan Stanley, Truist Cautious on DexCom Cites Weaker Gross Margins, Modest Q3 Beat - Finviz
11/25/2025
2
DexCom Stock Trades Down, Here Is Why - Yahoo Finance
01/08/2026
3
DexCom Releases Preliminary, Unaudited Results for Q4 2025 - Yahoo Finance UK
01/14/2026
4
Dexcom releases preliminary, unaudited results for Q4 2025 - MSN
01/19/2026
5
New DexCom CEO Remains Focused on Addressing Recent Quality Issues - Morningstar
01/23/2026
6
Strs Ohio Sells 14,796 Shares of DexCom, Inc. DXCM - MarketBeat
01/26/2026
7
Price Over Earnings Overview DexCom - Sahm
01/29/2026
8
A Look Into DexCom Incs Price Over Earnings - Sahm
02/06/2026
9
Dexcom Inc Beats Q4 Profit Estimates Despite Revenue Shortfall - ChartMill
02/12/2026
10
Dexcom Stock After Volatility Is This High-Growth Medtech Now Mispriced - AD HOC NEWS
02/17/2026
  

DexCom Relative Risk vs. Return Landscape

If you would invest  5,405  in DexCom Inc on November 26, 2025 and sell it today you would earn a total of  812.00  from holding DexCom Inc or generate 15.02% return on investment over 90 days. DexCom Inc is currently producing 0.2529% returns and takes up 1.9958% volatility of returns over 90 trading days. Put another way, 17% of traded stocks are less volatile than DexCom, and 95% of all traded equity instruments are likely to generate higher returns over the next 90 trading days.
  Expected Return   
       Risk  
Assuming the 90 days horizon DexCom is expected to generate 2.62 times more return on investment than the market. However, the company is 2.62 times more volatile than its market benchmark. It trades about 0.13 of its potential returns per unit of risk. The Dow Jones Industrial is currently generating roughly 0.08 per unit of risk.

DexCom Target Price Odds to finish over Current Price

The tendency of DexCom Stock price to converge on an average value over time is a known aspect in finance that investors have used since the beginning of the stock market for forecasting. However, many studies suggest that some traded equity instruments are consistently mispriced before traders' demand and supply correct the spread. One possible conclusion to this anomaly is that these stocks have additional risk, for which investors demand compensation in the form of extra returns.
Current PriceHorizonTarget PriceOdds to move above the current price in 90 days
 61.91 90 days 61.91 
about 9.03
Based on a normal probability distribution, the odds of DexCom to move above the current price in 90 days from now is about 9.03 (This DexCom Inc probability density function shows the probability of DexCom Stock to fall within a particular range of prices over 90 days) .
Assuming the 90 days horizon DexCom has a beta of 0.6 suggesting as returns on the market go up, DexCom average returns are expected to increase less than the benchmark. However, during the bear market, the loss on holding DexCom Inc will be expected to be much smaller as well. Additionally DexCom Inc has an alpha of 0.2753, implying that it can generate a 0.28 percent excess return over Dow Jones Industrial after adjusting for the inherited market risk (beta).
   DexCom Price Density   
       Price  

Predictive Modules for DexCom

There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as DexCom Inc. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.
Hype
Prediction
LowEstimatedHigh
59.8861.8863.88
Details
Intrinsic
Valuation
LowRealHigh
55.9570.8672.86
Details
Naive
Forecast
LowNextHigh
63.9065.8967.89
Details
Earnings
Estimates (0)
LowProjected EPSHigh
0.480.630.76
Details

DexCom Risk Indicators

For the most part, the last 10-20 years have been a very volatile time for the stock market. DexCom is not an exception. The market had few large corrections towards the DexCom's value, including both sudden drops in prices as well as massive rallies. These swings have made and broken many portfolios. An investor can limit the violent swings in their portfolio by implementing a hedging strategy designed to limit downside losses. If you hold DexCom Inc, one way to have your portfolio be protected is to always look up for changing volatility and market elasticity of DexCom within the framework of very fundamental risk indicators.
α
Alpha over Dow Jones
0.28
β
Beta against Dow Jones0.60
σ
Overall volatility
3.04
Ir
Information ratio 0.12

DexCom Alerts and Suggestions

In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of DexCom for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for DexCom Inc can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.
DexCom Inc is unlikely to experience financial distress in the next 2 years
DexCom Inc has high financial leverage indicating that it may have difficulties to generate enough cash to satisfy its financial obligations
Over 99.0% of the company shares are held by institutions such as insurance companies
Latest headline from news.google.com: Dexcom Stock After Volatility Is This High-Growth Medtech Now Mispriced - AD HOC NEWS

DexCom Fundamentals Growth

DexCom Stock prices reflect investors' perceptions of the future prospects and financial health of DexCom, and DexCom fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on DexCom Stock performance.

About DexCom Performance

By analyzing DexCom's fundamental ratios, stakeholders can gain valuable insights into DexCom's financial health, operational efficiency, and overall profitability, helping them make informed investment and management decisions. For instance, if DexCom has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if DexCom has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements.
DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring systems in the United States and internationally. DexCom, Inc. was founded in 1999 and is headquartered in San Diego, California. DEXCOM INC operates under Diagnostics Research classification in Germany and is traded on Frankfurt Stock Exchange. It employs 2800 people.

Things to note about DexCom Inc performance evaluation

Checking the ongoing alerts about DexCom for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for DexCom Inc help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
DexCom Inc is unlikely to experience financial distress in the next 2 years
DexCom Inc has high financial leverage indicating that it may have difficulties to generate enough cash to satisfy its financial obligations
Over 99.0% of the company shares are held by institutions such as insurance companies
Latest headline from news.google.com: Dexcom Stock After Volatility Is This High-Growth Medtech Now Mispriced - AD HOC NEWS
Evaluating DexCom's performance can involve analyzing a variety of financial metrics and factors. Some of the key considerations to evaluate DexCom's stock performance include:
  • Analyzing DexCom's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
  • Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether DexCom's stock is overvalued or undervalued compared to its peers.
  • Examining DexCom's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
  • Evaluating DexCom's management team can have a significant impact on its success or failure. Reviewing the track record and experience of DexCom's management team can help you assess the Company's leadership.
  • Pay attention to analyst opinions and ratings of DexCom's stock. These opinions can provide insight into DexCom's potential for growth and whether the stock is currently undervalued or overvalued.
It's essential to remember that evaluating DexCom's stock performance is not an exact science, and many factors can impact DexCom's stock market price. Therefore, it's also important to diversify your portfolio and not rely solely on one company or stock for your investments.

Complementary Tools for DexCom Stock analysis

When running DexCom's price analysis, check to measure DexCom's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy DexCom is operating at the current time. Most of DexCom's value examination focuses on studying past and present price action to predict the probability of DexCom's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move DexCom's price. Additionally, you may evaluate how the addition of DexCom to your portfolios can decrease your overall portfolio volatility.
Competition Analyzer
Analyze and compare many basic indicators for a group of related or unrelated entities
Global Markets Map
Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes
Investing Opportunities
Build portfolios using our predefined set of ideas and optimize them against your investing preferences
Bond Analysis
Evaluate and analyze corporate bonds as a potential investment for your portfolios.
Fundamental Analysis
View fundamental data based on most recent published financial statements
Equity Forecasting
Use basic forecasting models to generate price predictions and determine price momentum
Theme Ratings
Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance
AI Portfolio Prophet
Use AI to generate optimal portfolios and find profitable investment opportunities
Pattern Recognition
Use different Pattern Recognition models to time the market across multiple global exchanges